Question
We in America have a new president with a decidedly "America First" platform. Will it help American medtech? From the December 2016 LIMEDex Index: • Stricter oversight of public spending with an “America first” bias could significantly affect procure...
Obtaining market access in many countries through product registration is a daunting and mostly manual experience. I invite you to learn a better way on February 1 at our free http://medgroup.biz/mktaccess webinar. Today, registering products is subj...
Visit the website for AdvaMed, the Advanced Medical Technology Association which looks out for American interests, and you'll read: "The innovation ecosystem that supports medical technology is severely stressed. The U.S. has historically been the wo...
In 2016, the Medical Devices Group surpassed 340,000 members. We gave seven free webinars, hosted the fourth annual 10x Medical Device Conference, and many of us met in person, talked here, and made valuable business connections. Here are the most po...
Andrew Kyle
Medical Devices, Internet of Things, Agritech and Cannabis Speaker-Consultant
December 2016
It is time to change the attitude toward cannabis. This group has the voice that may make a difference. We are in the medical field to help and be blind to our individual prejudices. Even if you don't believe in cannabis, your prejudice should not co...
Under Trump, the medical device industry will likely be the first to benefit from tax cutsDonald Trump and the Republican-led Congress are likely to permanently repeal the medical device tax, according to lawmakers, lobbyists and industry...
My friend Stephen Carter from Mewburn Ellis gave a 10-minute talk about the European Unitary Patent Package at the 10x Medical Device Conference in May 2016 – before the Brexit vote. His worthwhile summary at http://medgroup.biz/EU-patents (free acce...
Kristin Benokraitis
Director of Quality and Operations at EG-GILERO: A trusted partner for medical and drug delivery devices
December 2016
We are working with a pharmaceutical company who, in the past, developed a combination product (drug/device). Because the device was included in the drug submission, it led to many questions, specifically about the device, by the agency because both ...
“Notified Bodies (NBs) are getting hit with a crush of work so great that you’re lucky to get a callback,” says Medical Devices Group Advisory Board member Rob Packard. NEW WORK: The European Parliament and EU Council are expected to approve the new ...
